The innovative drug concept has repeatedly strengthened, and JLPC has achieved 6 limit-ups in 8 days
The concept of innovative drugs has repeatedly strengthened, with popular stock JLPC achieving 6 limit-ups in 8 days, InventisBio rising over 5% to set a new historical high, and Li Sheng Pharmaceutical, Guangsheng Tang, Asia-Pacific Pharmaceutical, Livzon Pharmaceutical, and Anglikang all rising over 5%
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments